JENNIFER WALK: Open Payments
NPI 1346619095 · WASHINGTON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$228 in 14 payments from 10 companies in 2025. Trend: 2023 $57 · 2024 $316 · 2025 $228
Food & beverage: $228
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 2 | $34 |
| Otsuka America Pharmaceutical, Inc. | 2 | $31 |
| Exact Sciences Corporation | 2 | $30 |
| ABBVIE INC. | 2 | $30 |
| Dexcom, Inc. | 1 | $22 |
| Novo Nordisk Inc | 1 | $19 |
| Amphastar Pharmaceuticals, Inc. | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
| Sumitomo Pharma America, Inc. | 1 | $14 |
Products named: SHINGRIX, REXULTI, The Cologuard Plus Collection Kit, VRAYLAR, Dexcom G6 Transmitter, Rybelsus, BREZTRI, JARDIANCE.
Industry payments across MO — which companies pay providers there.
